PubMed:23241745 / 249-447
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T34 | 82-97 | GO:0016301 | denotes | kinase activity |
T35 | 110-115 | PR:Q5S006 | denotes | LRRK2 |
T36 | 110-115 | PR:000003033 | denotes | LRRK2 |
T37 | 110-115 | PR:Q5S007 | denotes | LRRK2 |
T38 | 168-173 | PR:Q5S006 | denotes | LRRK2 |
T39 | 168-173 | PR:000003033 | denotes | LRRK2 |
T40 | 168-173 | PR:Q5S007 | denotes | LRRK2 |
T41 | 174-189 | GO:0016301 | denotes | kinase activity |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-198 | DRI_Background | denotes | Although biochemical studies have shown that certain PD mutations confer elevated kinase activity in vitro on LRRK2, there are no methods available to directly monitor LRRK2 kinase activity in vivo. |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 0-198 | DRI_Background | denotes | Although biochemical studies have shown that certain PD mutations confer elevated kinase activity in vitro on LRRK2, there are no methods available to directly monitor LRRK2 kinase activity in vivo. |